method
improv
plasmidmedi
transgen
express
need
gene
medicin
gene
vaccin
applic
maintain
low
risk
insert
mutagenesismedi
gene
activ
expressionaug
sequenc
would
ideal
function
improv
transgen
express
transient
transfect
intact
plasmid
spuriou
genom
integr
vector
report
herein
develop
potent
minim
antibioticfre
highmanufacturingyield
mammalian
express
vector
incorpor
ration
design
addit
combin
express
enhanc
bp
enhanc
incorpor
upstream
cytomegaloviru
cmv
enhanc
select
improv
extrachromosom
transgen
express
human
tlymphotrop
viru
type
htlvi
r
region
incorpor
downstream
cmv
promot
dramat
increas
mrna
translat
effici
overal
mrna
level
transient
transfect
similar
mrna
translat
effici
increas
observ
plasmid
vector
incorpor
express
protein
kinas
rinhibit
adenovir
viral
associ
va
rna
strikingli
htlvi
r
increas
transgen
express
mrna
translat
effici
plasmid
dna
genom
integr
vector
platform
combin
electropor
deliveri
increas
transgen
express
improv
dna
vaccineinduc
neutral
antibodi
titer
rabbit
antibioticfre
vector
incorpor
transient
express
enhanc
safer
potent
altern
improv
transgen
express
dna
therapi
vaccin
gene
therapi
use
transient
express
nonintegr
plasmid
vector
ideal
solut
mani
public
health
applic
exampl
current
therapi
diabet
foot
ulcer
directli
improv
biolog
wound
heal
would
gene
therapi
use
hypoxiainduc
factor
master
regul
wound
heal
gene
topic
deliv
genebas
drug
ideal
growth
factor
replac
therapi
plasmid
far
longer
durat
express
compar
rapidli
degrad
recombin
peptid
extens
research
improv
plasmid
deliveri
result
advanc
method
electropor
ep
facilit
uptak
dramat
improv
gene
transfer
compar
passiv
dna
uptak
plasmiddirect
gene
express
reach
efficaci
barrier
date
prevent
commerci
genebas
plasmid
human
applic
although
plasmid
deliveri
focu
gene
transfer
research
complementari
vector
design
innov
may
also
appli
improv
transgen
express
previous
report
develop
potent
minim
antibioticfre
af
mammalian
express
vector
af
vector
deriv
pdnavaccultra
express
vector
incorpor
express
bp
rnaout
antisens
rna
repress
express
host
strain
chromosomeencod
counterselect
marker
sacbencod
levansucras
toxic
presenc
sucros
figur
sucros
select
vector
combin
af
select
highli
product
ferment
manufactur
g
l
plasmid
dna
yield
improv
transgen
express
level
compar
exist
vector
plasmid
design
remov
nonessenti
extran
sequenc
figur
minim
fda
food
drug
administr
compliant
vector
gene
therapi
genet
immun
applic
af
vector
also
compliant
european
regulatori
agenc
recommend
elimin
antibiot
resist
marker
plasmid
therapi
vector
although
individu
expressionaug
sequenc
identifi
use
combinatori
improv
vector
perform
report
herein
incorpor
ration
design
addit
combin
express
enhanc
optim
minimalist
af
vector
effect
improv
transgen
express
result
highproductionyield
minim
af
mammalian
express
vector
incorpor
novel
vector
backbon
function
improv
plasmiddirect
transgen
express
transient
transfect
transient
express
enhanc
tee
platform
figur
c
viral
human
tlymphotrop
viru
type
htlvi
r
adenovir
viral
associ
va
rnai
enhanc
use
studi
deriv
noncod
region
respect
virus
signific
sequenc
homolog
human
genom
studi
demonstr
dramat
increas
vectordirect
transgen
express
obtain
innov
vector
design
reduc
chanc
chromosom
integr
sequenc
ad
plasmid
increas
transgen
express
contain
signific
homolog
human
genom
may
determin
blast
search
specifi
search
short
nearli
exact
match
human
genom
region
encod
antigen
peptid
also
present
vector
backbon
includ
cryptic
open
read
frame
orf
bacteri
eukaryot
sequenc
may
express
eukaryot
cell
gener
unwant
potenti
detriment
cytotox
tcell
humor
respons
remov
spacer
junk
sequenc
use
rnabas
select
marker
elimin
kanamycinresist
kanr
orf
reduc
risk
figur
c
vector
incorpor
boundari
element
delet
figur
describ
herein
minim
vector
contain
extran
spacer
junk
sequenc
vector
incorpor
short
bp
rnabas
select
marker
rather
antibiot
resist
marker
figur
result
much
higher
vector
potenc
elimin
approxim
kb
dna
compar
gwiz
genlanti
san
diego
ca
usa
vector
includ
kanr
gene
associ
extran
dna
includ
plasmidfre
cell
levansucras
express
chromosom
integr
sacb
gene
lead
cell
death
presenc
sucros
right
rnaout
plasmid
repress
translat
sacb
gene
achiev
plasmid
select
b
egfp
af
vector
rnaout
select
marker
htlvi
r
transient
express
enhanc
c
egfp
af
vector
transient
express
enhanc
htlvi
r
enhanc
optim
boundari
delet
result
vector
improv
express
gwiz
egfp
kanr
vector
locat
nonessenti
spacer
junk
dna
invert
repeat
polyc
polyg
ampr
promot
annot
basepair
region
function
maintain
optim
junction
cmv
promot
prokaryot
backbon
sequenc
retain
equival
locat
vectorup
replac
enhanc
vector
vector
bp
region
move
ad
extens
puc
origin
add
back
lead
strand
primosom
assembl
site
pasbh
present
site
delet
puc
vector
creat
imprecis
delet
repressor
primer
rop
gene
pasbh
vector
higher
plasmid
copi
number
manufactur
yield
gwiz
transposon
invert
repeat
ampicillin
resist
marker
promot
polyc
polyg
tail
site
clone
footprint
figur
untransl
region
utr
utr
orf
translat
mani
dna
vaccin
vector
contain
singl
copi
human
woodchuck
hepat
b
viru
posttranscript
regulatori
element
pre
wpre
immedi
downstream
stop
codon
transcript
termin
element
commonli
use
retrovir
lentivir
vector
altern
lentivir
revrespons
element
direct
export
unsplic
fulllength
viral
genom
mrna
pre
element
includ
dna
vaccin
increas
splice
mrna
nuclear
export
transgen
express
howev
hepat
genom
highli
compact
enhanc
also
encod
aminoacid
fragment
hepat
c
viru
polymeras
gene
pre
design
within
eukaryot
express
cassett
type
design
known
gener
cell
reactiv
major
histocompat
complexi
epitop
cryptic
orf
antigen
region
might
significantli
alter
immun
respons
individu
previou
exposur
memori
cell
reactiv
hepat
assess
risk
quantifi
translat
code
region
insert
differ
read
frame
downstream
transgen
stop
codon
cytomegaloviru
cmv
promot
express
vector
neomycin
resist
gene
neor
without
upstream
kozak
sequenc
clone
downstream
enhanc
green
fluoresc
protein
egfp
transgen
differ
configur
similar
use
pre
quantifi
neor
translat
product
present
test
configur
biolog
activ
neor
protein
plasmid
transfect
cho
cell
line
supplementari
tabl
result
demonstr
express
enhanc
ideal
noncod
region
cryptic
orf
present
downstream
transgen
within
export
eukaryot
mrna
translat
even
orf
read
frame
upstream
transgen
although
number
utr
sequenc
identifi
use
increas
transgen
express
exampl
see
htlvi
r
element
potent
clone
downstream
transcript
start
site
htlvi
r
improv
express
varieti
promot
includ
cmv
improv
transgen
express
nonhuman
primat
cmvhtlvi
r
promot
plasmid
vector
found
safe
human
vaccin
nih
vaccin
research
centersponsor
clinic
trial
hiv
ebola
sever
acut
respiratori
syndrom
sar
dna
vaccin
cmvhtlvi
r
promot
htlvi
r
incorpor
part
exon
intron
downstream
cmv
promot
figur
configur
improv
dna
vaccin
express
immunogen
incorpor
htlvi
r
figur
dramat
increas
transgen
express
total
cellular
extract
figur
fluorescenceactiv
cell
sort
fac
sort
cell
figur
transient
transfect
due
increas
mrna
translat
effici
htlvi
r
increas
amount
egfp
transgen
produc
per
pg
cytoplasm
egfp
mrna
figur
due
increas
overal
cytoplasm
mrna
level
contrast
effect
integr
express
either
total
mean
fluoresc
fluoresc
per
integr
transgen
copi
observ
figur
supplementari
figur
cell
consist
cytoplasm
mrna
translat
effici
improv
observ
htlvi
r
transient
transfect
plasmid
occur
cytoplasm
rna
produc
genom
integr
plasmid
figur
interestingli
overal
amount
egfp
transgen
produc
per
pg
cytoplasm
egfp
mrna
dramat
higher
genom
integr
plasmid
compar
transient
transfect
plasmid
cmv
cmvhtlvi
r
promot
plasmid
figur
vivo
effect
htlvi
r
region
plasmid
vaccin
determin
rabbit
immun
rabbit
cmvhtlvi
r
promot
dna
vaccin
vector
combin
ep
deliveri
induc
log
higher
titer
virusneutr
antibodi
ic
compar
cmv
promot
vector
figur
improv
ic
titer
observ
neutralizationsensit
resist
jrcsf
virus
like
attribut
higher
express
cmvhtlvi
r
plasmid
result
demonstr
modifi
utr
vector
design
improv
vector
perform
vivo
combin
optim
dna
deliveri
platform
ep
activ
pkr
inhibit
mrna
translat
eukaryot
initi
phosphoryl
pkr
activ
either
ligand
doublestrand
rna
pkrassoci
activ
protein
pact
murin
cell
rax
ortholog
respons
divers
nonnucl
acidbas
cell
stress
includ
endoplasm
reticulum
stress
unfold
protein
respons
cell
stress
induc
certain
plasmid
deliveri
exampl
liposom
calcium
phosphat
formul
andor
express
aggregationpron
protein
exampl
hydrophob
membranedomaincontain
protein
polyepitop
synthet
protein
therefor
inclus
pkr
inhibitor
vector
backbon
may
improv
plasmidmedi
express
stress
condit
adenoviru
serotyp
va
rnai
epsteinbarr
viru
rna
noncod
rna
pol
iiiexpress
small
rnabas
pkr
inhibitor
va
rnai
includ
padvantag
vector
promega
madison
wi
usa
plasmid
backbon
increas
target
gene
express
cotransfect
plasmid
human
vaccin
va
rnai
prefer
bind
multipl
cellular
protein
document
cell
growthstimul
properti
advers
properti
attribut
natur
adenoviru
gene
present
multipl
adenovir
vector
evalu
human
clinic
trial
cmvhtlvi
r
promot
plasmid
encod
exampl
figur
increas
transgen
express
compar
parent
cmvhtlvi
r
promot
vector
transient
express
human
cell
figur
cmvhtlvi
rand
cmv
promoterdirect
transgen
express
level
affect
addit
rna
pol
iii
inhibitor
transfect
rna
pol
iii
independ
figur
contrast
expect
increas
transgen
express
rna
pol
iii
depend
inhibit
test
rna
pol
iii
inhibitor
concentr
figur
increas
transient
transfect
mrna
translat
effici
egfp
transgen
produc
per
pg
cytoplasm
egfp
mrna
supplementari
figur
effect
translat
effici
forc
integr
cell
egfp
protein
produc
per
integr
transgen
figur
htlvi
rdirect
transient
express
enhanc
also
observ
human
murin
cell
line
supplementari
figur
result
demonstr
htlvi
r
increas
translat
transient
express
mrna
effect
redund
variabl
activ
element
cell
line
probabl
reflect
differ
level
cellular
cofactor
requir
htlvi
r
activ
pkr
inhibit
may
account
increas
transgen
express
altern
pkrindepend
stimul
gene
express
may
inhibit
adenosin
deaminas
act
rna
rna
interfer
determin
test
effect
functionspecif
point
mutat
vectorencod
gene
figur
egfp
express
incorpor
mutat
bp
chang
central
domain
shown
inact
pkr
inhibit
yet
transcrib
high
level
cell
cultur
maintain
va
rnailik
rna
secondari
structur
necessari
rna
interfer
inhibit
incorpor
bp
chang
central
domain
strongli
reduc
pkr
inhibit
retain
adenosin
deaminas
act
rnainhibit
activ
va
rnailik
rna
secondari
structur
requir
rna
interfer
inhibit
result
figur
suggest
pkr
inhibit
adenosin
deaminas
act
rna
rna
interfer
inhibit
critic
transgen
express
enhanc
effect
lost
point
mutant
nuclear
membran
transit
enhanc
transient
express
enhanc
sequenc
incorpor
vector
backbon
improv
plasmid
nuclear
local
also
enhanc
nonvir
gene
express
dna
transport
nucleu
limit
factor
nondivid
cell
review
lam
dean
wagstaff
jan
sequenc
would
true
transient
express
enhanc
function
enhanc
plasmid
nuclear
entri
mrna
product
translat
could
also
affect
chromosom
gene
express
mechan
sequencespecif
plasmid
dna
nuclear
import
delin
number
dna
transcript
factor
bind
site
identifi
increas
plasmid
nuclear
import
ad
plasmid
vector
backbon
sever
incorpor
vector
backbon
evalu
improv
express
enhanc
inclus
bp
enhanc
upstream
downstream
express
cassett
dna
vaccin
vector
backbon
increas
vivo
express
use
ep
deliveri
muscl
tissu
enhanc
observ
vitro
vector
figur
contain
enhanc
two
copi
bp
repeat
figur
enhanc
region
part
promot
caus
safeti
concern
human
clinic
trial
promotercontain
vector
improv
manufactur
yield
improv
copi
number
mediat
enhanc
pasbh
replic
origin
configur
enhanc
cmv
promot
also
shown
improv
transgen
express
epmedi
deliveri
murin
muscl
expect
vitro
express
similar
vector
figur
treatment
tumor
necrosi
factora
induc
nuclear
local
nuclear
factorkb
nfkb
therebi
increas
transgen
express
activ
multipl
nfkb
site
cmv
promot
result
higher
express
figur
perhap
activ
two
nfkb
site
enhanc
figur
addit
three
nfkb
bind
site
improv
express
tumor
necrosi
factora
activ
figur
contain
atrich
uniqu
region
upstream
cmv
enhanc
uniqu
region
contain
boundari
domain
sever
bind
site
cellular
repressor
protein
cdp
figur
sequenc
may
interfer
enhanc
interact
cmv
promot
consist
delet
uniqu
region
cmv
enhanc
junction
creat
increas
transgen
express
divid
cell
compar
parent
vector
figur
c
enhanc
gener
improv
express
vitro
uniqu
region
delet
may
allow
enhancermedi
activ
cmv
promot
optim
configur
higher
express
without
tumor
necrosi
factora
approxim
higher
express
kanr
invitrogen
carlsbad
ca
usa
cmv
promot
vector
figur
enhanc
nfkb
site
substrat
e
coli
dcm
methylas
methyl
intern
cytosin
residu
recognit
sequenc
methyl
site
may
reduc
nfkb
bind
enhancermedi
activ
cmv
promot
optim
vector
consist
plasmid
produc
host
strain
much
higher
express
dcmplasmid
figur
express
level
vitro
ep
determin
human
dendrit
cell
dc
versu
cmv
promot
compar
supplementari
figur
three
ntc
cmvhtlvi
r
promot
vector
improv
express
compar
cmv
promot
vector
system
isol
divid
cell
subject
vitro
ep
strong
effect
encod
rna
enhanc
observ
although
highest
express
vector
three
donor
would
indic
cell
stress
induc
vitro
condit
cell
divis
elimin
need
nuclear
entri
report
li
et
al
nuclear
import
bind
protein
nfkb
nuclear
shuttl
protein
bind
site
increas
plasmid
nuclear
local
ad
base
vector
protein
specul
chromatin
modul
function
maintain
expressioncompet
euchromatin
associ
histon
acetyl
transferas
site
also
form
gquadruplex
structur
local
singlestrand
dna
region
singlestrand
threeloop
structur
form
interact
four
motif
three
link
loop
structur
exclud
nucleosom
recogn
varieti
dna
bind
enzym
may
function
nuclear
shuttl
protein
bind
site
protein
integr
backbon
express
divid
nondivid
aphidicolin
treat
improv
inclus
dna
bind
sequenc
nuclear
local
protein
nfkb
kb
figur
f
known
express
howev
express
base
vector
aphidicolintr
nondivid
figur
nondivid
figur
cell
much
higher
gwiz
compar
vector
produc
host
henc
differ
express
level
could
attribut
effect
plasmid
dcm
methyl
impli
nuclear
local
optim
ntc
backbon
inclus
addit
shuttl
protein
bind
site
redund
exist
nuclear
local
signal
present
vector
cell
growth
inhibit
mm
pol
iii
inhibitor
account
observ
reduc
fu
concentr
b
pol
iii
transcript
requir
express
enhanc
effect
assay
format
except
fact
pol
iii
inhibitortr
cell
transfect
egfp
plasmid
contain
cmvhtlvi
r
promot
without
c
inhibit
pkr
adenosin
deaminas
act
rna
adar
rna
interfer
rnai
requir
express
enhanc
effect
cell
transfect
backbon
except
kanr
instead
rnaout
contain
pkrrnaiadarinhibitor
inhibitor
incorpor
point
mutat
design
adar
use
effect
adar
inhibit
establish
incorpor
bp
chang
central
domain
increas
transgen
express
genom
integr
postintegr
express
kanr
gwiz
cmv
compar
af
gwiz
deriv
contain
cmvhtlvi
r
promot
instead
cmv
gene
cho
cell
transfect
egfpiresneo
transgen
version
plasmid
use
lipofectamin
ltx
quadrupl
use
four
differ
ratio
plasmid
ltx
integr
select
geneticin
day
result
present
nine
gener
post
select
total
mean
sd
fluoresc
egfp
extract
four
integr
cell
line
per
vector
fu
fu
per
integr
transgen
copi
number
per
genom
fucopi
shown
integr
copi
number
determin
use
rtpcr
quantif
egfp
transgen
isol
quantifi
genom
dna
report
develop
regulatoryagencycompli
minim
af
dna
vaccinegen
therapi
plasmid
vector
combin
g
l
ferment
yield
matrixattach
site
vector
tee
sequenc
increas
frequenc
genom
integr
william
et
al
manuscript
prepar
vector
famili
incorpor
variou
tee
combin
avail
allow
research
select
optim
combin
applic
tee
vector
could
also
adapt
improv
express
specif
cell
type
swap
altern
tissuespecif
cellular
promot
ubiquit
cmv
promot
three
transient
expressionaug
sequenc
identifi
incorpor
minim
af
vector
order
increas
vivo
express
encod
transgen
htlvi
r
region
insert
downstream
cmv
promot
dramat
increas
transgen
express
enhanc
mrna
translat
effici
similar
addit
mrna
translat
effici
increas
observ
plasmid
vector
incorpor
express
protein
kinas
r
pkr
inhibit
adenovir
va
rnai
final
enhanc
clone
upstream
cmv
enhanc
increas
transgen
express
nondivid
cell
importantli
vector
increas
transgen
express
plasmid
dna
forc
genom
integr
phenomenon
translat
stimul
restrict
extrachromosom
vectorderiv
mrna
previous
observ
attribut
local
activ
pkr
lead
translat
inhibit
eukaryot
initi
phosphoryl
similar
cisact
effect
htlvi
r
enhanc
transient
integr
plasmid
mrna
translat
mechanist
distinct
htlvi
r
effect
addit
critic
differ
transient
genom
produc
rna
transient
mrna
ineffici
translat
figur
may
due
aberr
mrna
splice
differenti
cytoplasm
mrna
local
alter
stabil
ribosom
boundrna
differ
ribosom
loadingcompositionst
transient
compar
genom
sourc
mrna
fragment
htlvi
r
incorpor
utr
may
allevi
transient
rnarestrict
effect
incorpor
dna
bind
site
nuclear
shuttl
protein
nfkb
vector
backbon
result
improv
nuclear
local
previou
studi
factor
lessoptim
vector
nuclear
local
capac
may
maxim
extens
optim
minim
vector
vector
platform
describ
herein
combin
advanc
deliveri
method
ep
increas
gene
express
led
improv
neutral
antibodi
titer
rabbit
epmedi
deliveri
htlvi
r
tee
vector
reduc
size
compar
altern
vector
may
critic
improv
gene
transfer
larg
transgen
dystrophin
larg
vector
reduc
transfect
effici
ep
deliveri
tee
vector
therefor
applic
gener
improv
dna
vaccin
gene
therapi
improv
may
critic
enabl
futur
gene
medicin
licensur
public
health
applic
vector
construct
use
standard
molecular
biolog
method
plasmid
contain
bp
draiiikpni
rnabas
sucros
select
marker
rnaout
incorpor
high
copi
number
backbon
kanr
vector
contain
three
copi
optim
nfkb
bind
site
underlin
insert
noti
site
bold
figur
contain
two
copi
optim
transcript
factor
bind
site
underlin
insert
noti
nhei
site
bold
contain
one
copi
cmyc
transcript
factor
bind
site
underlin
insert
noti
nhei
site
bold
vector
kanr
plasmid
grown
either
escherichia
coli
strain
coli
laczya
argf
mk
phoa
version
dcm
wherea
af
plasmid
grown
either
dcm
attl
cm
r
dcm
att
l
p
rnainsacb
cm
r
cell
cultur
immun
test
low
endotoxin
eu
mg
plasmid
dna
purifi
use
nucleobond
ax
ax
column
macherey
nagel
germani
indic
plasmid
dna
linear
restrict
enzym
digest
transfect
linear
plasmid
dna
purifi
phenolchloroform
extract
ethanol
precipit
resuspend
te
buffer
mm
tri
mm
edta
ph
transfect
adher
human
embryon
kidney
human
lung
carcinoma
murin
embryon
fibroblast
murin
areolar
fibroblast
chines
hamster
ovari
cell
line
obtain
american
type
cultur
collect
manassa
va
usa
cell
line
propag
dulbecco
modifi
eagl
contain
fetal
bovin
serum
split
trypsinedta
use
invitrogen
carlsbad
ca
usa
reagent
convent
methodolog
transfect
cell
plate
either
tissu
cultur
dish
supercoil
linear
plasmid
transfect
cell
line
use
lipofectamin
lipofectamin
ltx
follow
manufactur
instruct
invitrogen
analyz
durat
variabl
express
integr
egfpiresneo
transgen
transient
egfp
transgen
express
system
indic
plasmid
integr
select
use
media
contain
mg
ml
geneticin
invitrogen
day
total
cellular
lysat
egfp
determin
prepar
resuspend
cell
cell
lysi
buffer
bd
bioscienc
pharmingen
san
diego
ca
usa
lyse
cell
incub
min
follow
freezethaw
cycl
lyse
cell
clarifi
centrifug
supernat
assay
egfp
micropl
fluoresc
reader
biotek
winooski
vt
usa
singl
cell
suspens
fac
flow
cytometri
prepar
dissoci
cell
trypsin
treatment
wash
media
remov
trypsin
phosphatebuff
salin
fac
analysi
use
bd
franklin
lake
nj
usa
facscalibur
duallas
cytomet
transfect
nondivid
cell
describ
monkong
et
al
briefli
cell
pretreat
overnight
mg
ml
aphidicolin
sigma
st
loui
mo
usa
inhibit
cell
divis
synchron
cell
earli
phase
transfect
egfp
plasmid
outgrowth
perform
presenc
aphidicolin
cell
outgrowth
incub
without
ng
ml
tumor
necrosi
factora
invitrogen
h
induc
nfkb
nuclear
shuttl
fresh
medium
ad
total
cell
extract
prepar
egfp
fluoresc
determin
h
h
post
transfect
genom
dna
isol
integr
cell
line
use
dneasi
blood
tissu
kit
qiagen
scienc
germantown
md
usa
total
dna
quantifi
use
micropl
fluoresc
reader
biotek
determin
picogreen
invitrogen
fluoresc
sampl
versu
linear
vector
standard
curv
rtpcr
quantifi
vector
copi
genom
dna
perform
use
taqman
egfp
transgen
tctmgbnfq
probe
flank
primer
taqman
gene
express
assay
use
appli
biosystem
foster
citi
ca
usa
taqman
reagent
step
one
real
time
pcr
system
appli
biosystem
carlsbad
ca
usa
linear
vector
use
rtpcr
standard
curv
cytoplasm
rna
isol
transfect
cell
use
protein
rna
isol
system
pari
kit
ambion
austin
tx
usa
quantifi
sampl
dnase
treat
dnafre
dnase
ambion
revers
transcriptas
rtpcr
use
agpathid
one
step
rtpcr
kit
ambion
egfp
transgen
specif
probe
dnase
treatment
confirm
lack
detect
signal
control
rtpcr
reaction
run
without
initi
revers
transcriptas
step
use
heattreat
pcr
buffer
heat
treatment
inactiv
heatlabil
revers
transcriptas
taq
dna
polymeras
assay
linear
verifi
use
sampl
dilut
envelop
glycoprotein
gene
jrcsf
strain
clone
pmamp
af
backbon
pmamp
plasmid
describ
previous
contain
cmv
promot
intron
gene
express
bovin
growth
hormon
polyadenyl
site
vector
modifi
secret
transgen
use
tissu
plasminogen
activ
secret
leader
vector
express
ident
tissu
plasminogen
fusion
protein
plasmid
inject
rabbit
six
per
group
day
follow
ep
medpuls
electropor
system
inovio
biomed
san
diego
ca
usa
rabbit
bled
day
day
rabbit
receiv
booster
inject
alumadjuv
protein
rabbit
bled
day
studi
termin
sera
prepar
day
blood
sampl
measur
level
neutral
activ
neutral
test
two
neutralizationsensit
virus
two
resist
virus
jrcsf
rabbit
ep
viru
neutral
assay
describ
anim
studi
conduct
aldevron
fargo
nd
usa
approv
aldevron
institut
review
board
dc
three
independ
donor
gener
previous
describ
nucleofect
h
matur
use
amaxa
dc
nucleofect
kit
amaxa
koeln
germani
total
dc
prepar
per
manufactur
instruct
nucleofect
mg
plasmid
dna
subsequ
resuspend
complet
rpmi
media
fetal
bovin
serum
mmol
l
glutamax
mmol
l
sodium
pyruv
sigma
supplement
cytokin
matur
cocktail
contain
ng
ml
ng
ml
tumor
necrosi
factora
ng
ml
r
system
minneapoli
mn
usa
mg
ml
prostaglandin
sigma
u
ml
granulocyt
macrophag
colonystimul
factor
sargramostim
leukin
immunex
seattl
wa
usa
u
ml
r
system
nucleofect
effici
egfp
transgen
express
assess
h
nucleofect
use
bd
facscalibur
flow
cytomet
data
analyz
use
cell
quest
softwar
bd
